[[1] de Rooij M, Hamoen EH, Fütterer JJ, et al., Accuracy of multiparametric MRI for prostate cancer detection: a meta-analysis. American Journal of Roentgenology. 2014;202(2):343-351.10.2214/AJR.13.1104624450675]Search in Google Scholar
[[2] Shahbazi-Gahrouei D. Novel MR imaging contrast agents for cancer detection. Journal of Research in Medical Sciences. 2009;14(3):141-147.]Search in Google Scholar
[[3] Shahbazi-Gahrouei D, Rizvi S, Williams M, Allen BJ. In vitro studies of gadolinium-DTPA conjugated with monoclonal antibodies as cancer-specific magnetic resonance imaging contrast agents. Australasian Physics & Engineering Sciences in Medicine. 2002;25(1):31-38.10.1007/BF0317837212049473]Search in Google Scholar
[[4] Padmanabhan P, Kumar A, Kumar S, et al. Nanoparticles in practice for molecular-imaging applications: An overview. Acta Biomaterialia. 2016;41:1-16.10.1016/j.actbio.2016.06.00327265153]Search in Google Scholar
[[5] Shahbazi-Gahrouei D, Williams M, Rizvi S, Allen BJ. In vivo studies of Gd-DTPA-monoclonal antibody and gd-porphyrins: Potential magnetic resonance imaging contrast agents for melanoma. Journal of Magnetic Resonance Imaging. 2001;14(2):169-174.10.1002/jmri.116811477676]Search in Google Scholar
[[6] Abdolahi M, Shahbazi-Gahrouei D, Laurent S, et al. Synthesis and in vitro evaluation of MR molecular imaging probes using J591 mAb-conjugated SPIONs for specific detection of prostate cancer. Contrast Media and Molecular Imaging, 2013;8(2):175-184.10.1002/cmmi.151423281290]Search in Google Scholar
[[7] Mirzaei M, Mohagheghi M, Shahbazi-Gahrouei D, Khatami A. Novel nanosized Gd3+-ALGD-G2-C595: in vivo dual selective MUC-1 positive tumor molecular MR imaging and therapeutic agent. J Nanomed Nanotechnol. 2012;3(7):147-152.10.4172/2157-7439.1000147]Search in Google Scholar
[[8] Shahbazi-Gahrouei D, Williams M, Allen B. In vitro study of relationship between signal intensity and gadolinium-DTPA concentration at high magnetic field strength. Australasian Radiology. 2001;45(3):298-304.10.1046/j.1440-1673.2001.00924.x11531752]Search in Google Scholar
[[9] Shahbazi-Gahrouei D, Abdolahi M. A novel method for quantitative analysis of anti-MUC1 expressing ovarian cancer cell surface based on magnetic cell separation. Journal of Medical Sciences. 2012;12(8):256-266.10.3923/jms.2012.256.266]Search in Google Scholar
[[10] Shahbazi-Gahrouei D, Abdolahi M. Superparamagnetic iron oxide-C595: Potential MR imaging contrast agents for ovarian cancer detection. Journal of Medical Physics. 2013;38(4):198-204.10.4103/0971-6203.121198395900024672155]Search in Google Scholar
[[11] Shahbazi-Gahrouei D, Abdolahi M. Detection of MUC1-expressing ovarian cancer by C595 monoclonal antibody-conjugated SPIONs using MR imaging. The Scientific World Journal. 2013;2013:609151.10.1155/2013/609151380649024194685]Search in Google Scholar
[[12] Ghasemian Z, Shahbazi-Gahrouei D, Manouchehri S. Cobalt zinc ferrite nanoparticles as a potential magnetic resonance imaging agent: An in vitro study. Avicenna Journal of Medical Biotechnology. 2015;7(2):64-68.]Search in Google Scholar
[[13] Zahraei M, Marciello M, Lazaro-Carrillo A, et al. Versatile theranostics agents designed by coating ferrite nanoparticles with biocompatible polymers. Nanotechnology. 2016;27(25):255702.10.1088/0957-4484/27/25/25570227184442]Search in Google Scholar
[[14] Zahraei M, Monshi A, del Puerto Morales M, et al. Hydrothermal synthesis of fine stabilized superparamagnetic nanoparticles of Zn2+ substituted manganese ferrite. Journal of Magnetism and Magnetic Materials. 2015;393:429-436.10.1016/j.jmmm.2015.06.006]Search in Google Scholar
[[15] Hattrup L, Gendler J. MUC1 alters oncogenic events and transcription in human breast cancer cells. Breast Cancer Research. 2006;8(4):R37.10.1186/bcr1515177946016846534]Search in Google Scholar
[[16] Wang L, Ma J, Liu F, et al. Expression of MUC1 in primary and metastatic human epithelial ovarian cancer and its therapeutic significance. Gynecologic Oncology. 2007;105(3):695-702.10.1016/j.ygyno.2007.02.00417368732]Search in Google Scholar
[[17] Boult K, Borri M, Jury A, et al. Investigating intracranial tumour growth patterns with multiparametric MRI incorporating Gd-DTPA and USPIO-enhanced imaging. NMR in Biomedicine. 2016;29(11):1608-1617.10.1002/nbm.3594508256127671990]Search in Google Scholar
[[18] Danhier P, Magat J, Levêque P, et al. In vivo visualization and ex vivo quantification of murine breast cancer cells in the mouse brain using MRI cell tracking and electron paramagnetic resonance. NMR in Biomedicine. 2015;28(3):367-375.10.1002/nbm.325925611487]Search in Google Scholar
[[19] Estelrich J, Sánchez-Martín J, Busquets A. Nanoparticles in magnetic resonance imaging: from simple to dual contrast agents. International Journal of Nanomedicine. 2015;10:1727-1741.10.2147/IJN.S76501]Search in Google Scholar
[[20] Seyfer P, Pagenstcher A, Mandic R, et al. Cancer and inflammation: Differentiation by USPIO-enhanced MR imaging. Journal of Magnetic Resonance Imaging. 2014;39(3):665-672.10.1002/jmri.2420023723131]Search in Google Scholar
[[21] Neuwelt A, Sidhu N, Hu C, et al. Iron-based superparamagnetic nanoparticle contrast agents for MRI of infection and inflammation. American Journal of Roentgenology. 2015;204(3):W302-W313.10.2214/AJR.14.12733439503225714316]Search in Google Scholar
[[22] Kandasamy G, Maity D. Recent advances in superparamagnetic iron oxide nanoparticles (SPIONs) for in vitro and in vivo cancer nanotheranostics. International Journal of Pharmaceutics. 2015;496(2):191-218.10.1016/j.ijpharm.2015.10.05826520409]Search in Google Scholar
[[23] Vidavsky N, Kunitake A, Chiou E, et al. Studying biomineralization pathways in a 3D culture model of breast cancer microcalcifications. Biomaterials. 2018;179:71-84.10.1016/j.biomaterials.2018.06.030674770429980076]Search in Google Scholar
[[24] Talari S, Raza A, Rehman S, Rehman IU. Analyzing normal proliferating, hypoxic and necrotic regions of T-47D human breast cancer spheroids using Raman spectroscopy. Applied Spectroscopy Reviews. 2017;52(10):909-924.10.1080/05704928.2017.1363053]Search in Google Scholar
[[25] Khaniabadi M, Majik AMSA; Asif M, et al. Breast cancer cell targeted MR molecular imaging probe: Anti-MUC1 antibody-based magnetic nanoparticles. Journal of Physics: Conference Series. 2017;851:012014.10.1088/1742-6596/851/1/012014]Search in Google Scholar
[[26] Khaniabadi M, Shahbazi-Gahrouei D, Suhaimi M, et al. In vitro study of SPIONs-C595 as molecular imaging probe for specific breast cancer (MCF-7) cells detection. Iranian Biomedical Journal. 2017;21(6):360-368.]Search in Google Scholar
[[27] Khaniabadi M, Shahbazi-Gahrouei D, Jafaar S, et al. Magnetic iron oxide nanoparticles as T2 MR imaging contrast agent for detection of breast cancer (MCF-7) cell. Avicenna Journal of Medical Biotechnology. 2017;9(4):181-188.]Search in Google Scholar
[[28] Jafari F, Khadeer B, Iqbal A, et al. Increased aqueous solubility and proapoptotic activity of potassium koetjapate against human colorectal cancer cells. Journal of Pharmacy and Pharmacology. 2014;66(10):1394-1409.10.1111/jphp.1227225039905]Search in Google Scholar
[[29] Funovics A, Kapeller B, Hoeller C, et al. MR imaging of the her2/neu and 9.2. 27 tumor antigens using immunospecific contrast agents. Magnetic Resonance Imaging. 2004;22(6):843-850.10.1016/j.mri.2004.01.05015234453]Search in Google Scholar
[[30] Oghabian M, Jeddi-Tehrani M, Zolfaghari A, et al. Detectability of Her2 positive tumors using monoclonal antibody conjugated iron oxide nanoparticles in MRI. Journal of Nanoscience and Nanotechnology. 2011;11(6):5340-5344.10.1166/jnn.2011.377521770186]Search in Google Scholar
[[31] Arancibia S, Barrientos A, Torrejón J, et al. Copper oxide nanoparticles recruit macrophages and modulate nitric oxide, proinflammatory cytokines and PGE2 production through arginase activation. Nanomedicine. 2016;11(10):1237-1251.10.2217/nnm.16.3927079258]Search in Google Scholar
[[32] Zhang J, Ring L, Hurley R, et al. Quantification and biodistribution of iron oxide nanoparticles in the primary clearance organs of mice using T1 contrast for heating. Magnetic Resonance in Medicine. 2017;78(2):702-712.10.1002/mrm.26394536608927667655]Search in Google Scholar
[[33] Rodríguez E, Simoes V, Roig A, et al. An iron-based T 1 contrast agent made of iron-phosphate complexes: In vitro and in vivo studies. Magnetic Resonance Materials in Physics, Biology and Medicine. 2007;20(1):27-37.10.1007/s10334-006-0066-717268782]Search in Google Scholar
[[34] Callaghan F, Mohammadi S, Weiskopf N. Synthetic quantitative MRI through relaxometry modelling. NMR in Biomedicine. 2016;29(12):1729-1738.10.1002/nbm.3658513208627753154]Search in Google Scholar